Delivery Order SPE2DR25D3103-SPE2DR26F9Y30
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,187.81 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials. This is a firm fixed-price contract with an ultimate completion date of January 12, 2026, and represents a competitively awarded, non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. AmerisourceBergen Drug Corp is a subsidiary of...
- On January 8, 2026, the Defense Logistics Agency awarded a delivery order valued at $4,845.45 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials. This firm fixed-price delivery order, with an ultimate completion date of January 9, 2026, represents a competitively awarded non-set-aside contract with performance at the awardee's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,449.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Procainamide 1 gram/10 milliliter vials (10 milliliters total). The contract is set to be completed by January 2, 2026, with performance to take place at the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive child contract under AmerisourceBergen Drug Corp's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials on January 5, 2026, with a ceiling value of $1,577.22. This firm fixed-price delivery order represents a non-competitive set-aside and is scheduled for completion by January 6, 2026. The award will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $2,251.23 delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 9, 2026, for the supply of Procainamide 1 gram/10 milliliter vials. This firm fixed-price delivery order is scheduled for completion by January 12, 2026, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,566.00 firm fixed-price delivery order for Procainamide 1 gram/10 mL vials on November 24, 2025, with completion targeted for November 25, 2025. The award, which carries no set-aside designation, represents a competitively awarded delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $3,164.53. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,505.03. This is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $7,465.68. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,379.65 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials. This firm fixed-price delivery order, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, represents a direct procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9Y30Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,472.18 to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Procainamide 1 gram/10 milliliter vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 20, 2026, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems, particularly military and veteran medical programs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, vials, and specialized medical commodities across multiple therapeutic domains. The company's contract awards demonstrate its established capability to meet federal procurement requirements through open competition and its critical role in the Department of Defense supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 1/15/26 |